Pfizer’s announcement of positive trial results for its RSV vaccine, Abrysvo, in high-risk adults under...
Pfizer
Pfizer aims to sell roughly 630 million shares of Haleon, a company created to handle...
Pfizer’s announcement of positive trial results for its RSV vaccine, Abrysvo, in high-risk adults under...
Pfizer aims to sell roughly 630 million shares of Haleon, a company created to handle...